Effect of spironolactone on patients with atrial fibrillation and structural heart disease.
about
Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillationPolyunsaturated Fatty acids in atrial fibrillation: looking for the proper candidates.Impact of chronic kidney disease on risk of incident atrial fibrillation and subsequent survival in medicare patients.Diurnal Cortisol Rhythm Is Associated With Adverse Cardiac Events and Mortality in Coronary Artery Bypass PatientsAtrial fibrillation: mechanisms, therapeutics, and future directions.Atrial fibrillation in heart failure: drug therapies for rate and rhythm control.Mineralocorticoid receptor and cardiac arrhythmia.Novel therapeutic targets in the management of atrial fibrillation.[Basic mechanisms of the new antiarrhythmic drugs in atrial fibrillation].Chronic atrial ionic remodeling by aldosterone: potentiation of L-type Ca2+ channels and its arrhythmogenic significance.Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry.Spironolactone inhibits production of proinflammatory mediators in response to lipopolysaccharide via inactivation of nuclear factor-κB.
P2860
Q33680031-05B48142-8DB6-41EF-9ADE-EAB5D07DB19FQ36254295-9225016C-D437-4FEA-B7DB-DD42E99B8729Q36366261-EDE12B5A-EFBD-447B-B123-37A8776EFBB9Q36958413-D7E09FC6-4F9B-4AC9-ABFD-E3591A95BB9AQ37590158-A0A6623A-86F4-4BC2-B994-88510A4EF451Q38108265-21CFBC15-ECD3-449B-9286-000C53D2F5AEQ38124345-229F5FD9-5D46-4235-A4E2-B9733DC1DB7AQ38236746-9043028A-3BE9-4F62-A0DD-40DD08B718E9Q41560451-ACE3A543-45BB-4857-88F2-1ACDABAD5187Q48353759-C8398EA2-EC55-4818-BFEB-8D0CE1362453Q52589130-6D663844-285D-4869-894D-7D9D0029789AQ54350807-699FCED0-92A1-47C7-A69B-9301C7069564
P2860
Effect of spironolactone on patients with atrial fibrillation and structural heart disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Effect of spironolactone on pa ...... and structural heart disease.
@ast
Effect of spironolactone on pa ...... and structural heart disease.
@en
type
label
Effect of spironolactone on pa ...... and structural heart disease.
@ast
Effect of spironolactone on pa ...... and structural heart disease.
@en
prefLabel
Effect of spironolactone on pa ...... and structural heart disease.
@ast
Effect of spironolactone on pa ...... and structural heart disease.
@en
P2093
P2860
P356
P1433
P1476
Effect of spironolactone on pa ...... and structural heart disease.
@en
P2093
James A deLemos
Joan Reisch
Joseph A Hill
R Haris Naseem
Ryan S Williams
Vassilis Dimas
P2860
P304
P356
10.1002/CLC.20914
P577
2011-06-14T00:00:00Z